{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T13:51:50Z","timestamp":1781099510539,"version":"3.54.1"},"reference-count":170,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cvsm.2020.07.010","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T23:41:23Z","timestamp":1597534883000},"page":"1327-1349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia"],"prefix":"10.1016","volume":"50","author":[{"given":"Robert","family":"Goggs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1749-6632.1965.tb18956.x","article-title":"Autoimmune diseases in domestic animals","volume":"124","author":"Lewis","year":"1965","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1746-6148-7-15","article-title":"Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study","volume":"7","author":"Piek","year":"2011","journal-title":"BMC Vet Res"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jvim.12028","article-title":"Systematic review of evidence relating to the treatment of immune-mediated hemolytic anemia in dogs","volume":"27","author":"Swann","year":"2013","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jvim.15441","article-title":"ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats","volume":"33","author":"Garden","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/jvim.15463","article-title":"ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs","volume":"33","author":"Swann","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3\u20134","key":"10.1016\/j.cvsm.2020.07.010_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-2427(97)00032-9","article-title":"Proliferative responses of peripheral blood mononuclear cells from normal dogs and dogs with autoimmune haemolytic anaemia to red blood cell antigens","volume":"59","author":"Corato","year":"1997","journal-title":"Vet Immunol Immunopathol"},{"issue":"7","key":"10.1016\/j.cvsm.2020.07.010_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1748-5827.2011.01074.x","article-title":"Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs","volume":"52","author":"Swann","year":"2011","journal-title":"J\u00a0Small Anim Pract"},{"issue":"8","key":"10.1016\/j.cvsm.2020.07.010_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jsap.12107","article-title":"Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011)","volume":"54","author":"Wang","year":"2013","journal-title":"J\u00a0Small Anim Pract"},{"issue":"11","key":"10.1016\/j.cvsm.2020.07.010_bib9","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2460\/javma.2005.226.1869","article-title":"Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002)","volume":"226","author":"Weinkle","year":"2005","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib10","first-page":"763","article-title":"Developing randomized clinical trials to evaluate treatment effects in canine IMHA","volume":"26","author":"Goggs","year":"2016","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5326\/15473317-37-3-220","article-title":"Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia","volume":"37","author":"Scott-Moncrieff","year":"2001","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"issue":"5","key":"10.1016\/j.cvsm.2020.07.010_bib12","first-page":"504","article-title":"Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs","volume":"16","author":"Carr","year":"2002","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2460\/javma.1989.195.02.246","article-title":"Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982-1987)","volume":"195","author":"Klein","year":"1989","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib14","first-page":"12","article-title":"American College of Veterinary Emergency and Critical Care (ACVECC) Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines: Small animal","volume":"29","author":"Goggs","year":"2019","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib15","first-page":"37","article-title":"Consensus on the rational use of antithrombotics in veterinary critical care (CURATIVE): domain 1-defining populations at risk","volume":"29","author":"deLaforcade","year":"2019","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1939-1676.2010.0656.x","article-title":"A\u00a0prospective study of clopidogrel therapy in dogs with primary immune-mediated hemolytic anemia","volume":"25","author":"Mellett","year":"2011","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00251-015-0894-6","article-title":"Evaluation of a DLA-79 allele associated with multiple immune-mediated diseases in dogs","volume":"68","author":"Friedenberg","year":"2016","journal-title":"Immunogenetics"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1399-0039.2006.00715.x","article-title":"Association of a common dog leucocyte antigen class II haplotype with canine primary immune-mediated haemolytic anaemia","volume":"68","author":"Kennedy","year":"2006","journal-title":"Tissue Antigens"},{"issue":"12","key":"10.1016\/j.cvsm.2020.07.010_bib19","doi-asserted-by":"crossref","first-page":"e0168296","DOI":"10.1371\/journal.pone.0168296","article-title":"Characterisation of the Immunophenotype of Dogs with Primary Immune-Mediated Haemolytic Anaemia","volume":"11","author":"Swann","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jsap.12037","article-title":"Characterisation of changes in the haemostasis system in dogs with thrombosis","volume":"54","author":"Bauer","year":"2013","journal-title":"J\u00a0Small Anim Pract"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1177\/104063870902100606","article-title":"Reference intervals and method optimization for variables reflecting hypocoagulatory and hypercoagulatory states in dogs using the STA Compact (R) automated analyzer","volume":"21","author":"Bauer","year":"2009","journal-title":"J\u00a0Vet Diagn Invest"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib22","first-page":"42","article-title":"Diagnosis and treatment of platelet hyperactivity in relation to thrombosis in dogs and cats","volume":"22","author":"Wiinberg","year":"2012","journal-title":"J\u00a0Vet Emerg Crit Care"},{"key":"10.1016\/j.cvsm.2020.07.010_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tvjl.2016.03.027","article-title":"Using the laboratory to predict thrombosis in dogs: An achievable goal?","volume":"215","author":"Jeffery","year":"2016","journal-title":"Vet J"},{"issue":"10","key":"10.1016\/j.cvsm.2020.07.010_bib24","first-page":"1065","article-title":"Diagnostic utility of thoracic radiographs and abdominal ultrasound in canine immune-mediated hemolytic anemia","volume":"60","author":"Andres","year":"2019","journal-title":"Can Vet J"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib25","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/jvim.12430","article-title":"Effect of duration of packed red blood cell storage on morbidity and mortality in dogs after transfusion: 3,095 cases (2001-2010)","volume":"28","author":"Hann","year":"2014","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib26","first-page":"108","article-title":"Retrospective evaluation of the effect of red blood cell product age on occurrence of acute transfusion-related complications in dogs: 210 cases (2010-2012)","volume":"27","author":"Maglaras","year":"2017","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5326\/0400446","article-title":"Effect of a single plasma transfusion on thromboembolism in 13 dogs with primary immune-mediated hemolytic anemia","volume":"40","author":"Thompson","year":"2004","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"issue":"3\u20134","key":"10.1016\/j.cvsm.2020.07.010_bib28","first-page":"160","article-title":"Evaluation of different prognostic markers in dogs with primary immune-mediated hemolytic anemia","volume":"123","author":"Griebsch","year":"2010","journal-title":"Berl Munch Tierarztl Wochenschr"},{"issue":"8","key":"10.1016\/j.cvsm.2020.07.010_bib29","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2460\/ajvr.77.8.877","article-title":"Prevalence of naturally occurring antibodies against dog erythrocyte antigen 7 in a population of dog erythrocyte antigen 7-negative dogs from Spain and Italy","volume":"77","author":"Spada","year":"2016","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/1040638716668626","article-title":"Activity, specificity, and titer of naturally occurring canine anti-DEA 7 antibodies","volume":"28","author":"Spada","year":"2016","journal-title":"J\u00a0Vet Diagn Invest"},{"key":"10.1016\/j.cvsm.2020.07.010_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.tcam.2018.12.005","article-title":"Transfusion medicine: an update on antigens, antibodies and serologic testing in dogs and cats","volume":"34","author":"Zaremba","year":"2019","journal-title":"Top Companion Anim Med"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2460\/javma.250.3.303","article-title":"Incidence of incompatible crossmatch results in dogs admitted to a veterinary teaching hospital with no history of prior red blood cell transfusion","volume":"250","author":"Odunayo","year":"2017","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2460\/ajvr.73.2.213","article-title":"Comparison of gel column, card, and cartridge techniques for dog erythrocyte antigen 1.1 blood typing","volume":"73","author":"Seth","year":"2012","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/1040638718806023","article-title":"Comparison of cross-matching method for detection of DEA 7 blood incompatibility","volume":"30","author":"Spada","year":"2018","journal-title":"J\u00a0Vet Diagn Invest"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib35","first-page":"262","article-title":"Comparison of a commercial blood cross-matching kit to the standard laboratory method for establishing blood transfusion compatibility in dogs","volume":"26","author":"Guzman","year":"2016","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1939-1676.2000.tb01496.x","article-title":"Gastric mucosal lesions in dogs with acute intervertebral disc disease: characterization and effects of omeprazole or misoprostol","volume":"14","author":"Neiger","year":"2000","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4102\/jsava.v74i3.515","article-title":"The prevalence of subclinical gastroduodenal ulceration in Dachshunds with intervertebral disc prolapse","volume":"74","author":"Dowdle","year":"2003","journal-title":"J\u00a0S Afr Vet Assoc"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2796.1994.tb00855.x","article-title":"Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy","volume":"236","author":"Conn","year":"1994","journal-title":"J\u00a0Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaad.2016.02.1239","article-title":"Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Gastrointestinal and endocrinologic side effects","volume":"76","author":"Caplan","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1939-1676.2010.0651.x","article-title":"Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs","volume":"25","author":"Tolbert","year":"2011","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib41","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/jvim.12555","article-title":"Efficacy of intravenous administration of combined acid suppressants in healthy dogs","volume":"29","author":"Tolbert","year":"2015","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/FTD.0b013e31816337b7","article-title":"Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation","volume":"30","author":"Miura","year":"2008","journal-title":"Ther Drug Monit"},{"issue":"8","key":"10.1016\/j.cvsm.2020.07.010_bib43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/vr.109.8.150","article-title":"Primary autoimmune haemolytic anaemia in the dog","volume":"109","author":"Bennett","year":"1981","journal-title":"Vet Rec"},{"issue":"11","key":"10.1016\/j.cvsm.2020.07.010_bib44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1748-5827.1996.tb02313.x","article-title":"Serial monitoring of clinical, haematological and immunological parameters in canine autoimmune haemolytic anaemia","volume":"37","author":"Day","year":"1996","journal-title":"J\u00a0Small Anim Pract"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib45","first-page":"121","article-title":"The autoimmune hemolytic-anemia (AIHA) in dogs - A survey of the clinical picture, diagnosis and therapy of 8 cases","volume":"75","author":"Schwendenwein","year":"1988","journal-title":"Wien Tierarztl Monatsschr"},{"issue":"5","key":"10.1016\/j.cvsm.2020.07.010_bib46","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5326\/15473317-35-5-384","article-title":"Immune-mediated hemolytic anemia: 70 cases (1988-1996)","volume":"35","author":"Reimer","year":"1999","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2460\/javma.2001.218.543","article-title":"Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999)","volume":"218","author":"Grundy","year":"2001","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1024\/0036-7281.144.4.180","article-title":"Use of human intravenous immunoglobulin in dogs with primary immunmediated hemolytic anemia","volume":"144","author":"Gerber","year":"2002","journal-title":"Schweiz Arch Tierheilkd"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib49","first-page":"206","article-title":"Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: a randomized controlled clinical trial","volume":"17","author":"Mason","year":"2003","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib50","first-page":"158","article-title":"Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia","volume":"19","author":"Whelan","year":"2009","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14405\/kjvr.2016.56.3.139","article-title":"Prognostic factors and efficacy of human intravenous immunoglobulin G in dogs with idiopathic immune-mediated hemolytic anemia: a retrospective study","volume":"56","author":"Park","year":"2016","journal-title":"Korean J Vet Res"},{"issue":"25","key":"10.1016\/j.cvsm.2020.07.010_bib52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/vr.105104","article-title":"Randomised controlled trial of fractionated and unfractionated prednisolone regimens for dogs with immune-mediated haemolytic anaemia","volume":"184","author":"Swann","year":"2019","journal-title":"Vet Rec"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/01652176.2011.604979","article-title":"Canine idiopathic immune-mediated haemolytic anaemia: a review with recommendations for future research","volume":"31","author":"Piek","year":"2011","journal-title":"Vet Q"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jvim.12514","article-title":"Systematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemia","volume":"29","author":"Swann","year":"2015","journal-title":"J\u00a0Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib55","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jvim.13642","article-title":"Predicting outcome in dogs with primary immune-mediated hemolytic anemia: results of a multicenter case registry","volume":"29","author":"Goggs","year":"2015","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1532-950X.2006.00121.x","article-title":"Results of clinical renal transplantation in 15 dogs using triple drug immunosuppressive therapy","volume":"35","author":"Gregory","year":"2006","journal-title":"Vet Surg"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib57","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1532-950X.2011.00924.x","article-title":"Outcome after renal transplantation in 26 dogs","volume":"41","author":"Hopper","year":"2012","journal-title":"Vet Surg"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1748-5827.2011.01024.x","article-title":"Immunomodulatory drugs and their application to the management of canine immune-mediated disease","volume":"52","author":"Whitley","year":"2011","journal-title":"J\u00a0Small Anim Pract"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib59","first-page":"456","article-title":"Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide","volume":"14","author":"Burgess","year":"2000","journal-title":"J\u00a0Vet Intern Med"},{"issue":"11","key":"10.1016\/j.cvsm.2020.07.010_bib60","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/vr.163.11.323","article-title":"Concurrent immune-mediated haemolytic anaemia and severe thrombocytopenia in 21 dogs","volume":"163","author":"Goggs","year":"2008","journal-title":"Vet Rec"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib61","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1939-1676.2008.0060.x","article-title":"Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs","volume":"22","author":"Piek","year":"2008","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1 Pt 2","key":"10.1016\/j.cvsm.2020.07.010_bib62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1399-0012.1996.tb00657.x","article-title":"Molecular mechanisms of new immunosuppressants","volume":"10","author":"Halloran","year":"1996","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib63","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1939-1676.2010.0505.x","article-title":"Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs","volume":"24","author":"Helmond","year":"2010","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib64","first-page":"488","article-title":"Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia","volume":"26","author":"Morassi","year":"2016","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib65","first-page":"273","article-title":"Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases","volume":"25","author":"Panek","year":"2015","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib66","first-page":"389","article-title":"Prednisone and cyclosporine vs. prednisone alone for treatment of canine immune mediated hemolytic anemia (IMHA)","volume":"18","author":"Husbands","year":"2004","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib67","doi-asserted-by":"crossref","first-page":"228.e50","DOI":"10.1111\/vde.12222","article-title":"Comparison of the stability and pharmacokinetics in dogs of modified ciclosporin capsules stored at -20 degrees C and room temperature","volume":"26","author":"Bachtel","year":"2015","journal-title":"Vet Dermatol"},{"issue":"2\u20133","key":"10.1016\/j.cvsm.2020.07.010_bib68","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"issue":"7","key":"10.1016\/j.cvsm.2020.07.010_bib69","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/cr900021w","article-title":"IMP dehydrogenase: structure, mechanism, and inhibition","volume":"109","author":"Hedstrom","year":"2009","journal-title":"Chem Rev"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib70","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/jvp.12731","article-title":"Mycophenolic acid in patients with immune-mediated inflammatory diseases: From humans to dogs","volume":"42","author":"Klotsman","year":"2019","journal-title":"J\u00a0Vet Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib71","first-page":"226","article-title":"Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs","volume":"24","author":"West","year":"2014","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.17236\/sat00151","article-title":"Efficacy of the combination of glucocorticoids, mycophenolate-mofetil and human immunoglobulin for the therapy of immune mediated haemolytic anaemia in dogs","volume":"160","author":"Oggier","year":"2018","journal-title":"Schweiz Arch Tierheilkd"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib73","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/jsap.12203","article-title":"Treatment of five haemodynamically stable dogs with immune-mediated thrombocytopenia using mycophenolate mofetil as single agent","volume":"55","author":"Yau","year":"2014","journal-title":"J\u00a0Small Anim Pract"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib74","first-page":"229","article-title":"Therapy of immune-mediated haemolytic anaemia in the dog using human immunoglobulin","volume":"29","author":"Link","year":"2001","journal-title":"Tierarztl Prax Ausg K Kleintiere Heimtiere"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib75","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1939-1676.1997.tb00475.x","article-title":"Intravenous human immunoglobulin for the treatment of immune-mediated hemolytic anemia in 13 dogs","volume":"11","author":"Kellerman","year":"1997","journal-title":"J\u00a0Vet Intern Med"},{"issue":"11","key":"10.1016\/j.cvsm.2020.07.010_bib76","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2460\/javma.1997.210.11.1623","article-title":"Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia","volume":"210","author":"Scott-Moncrieff","year":"1997","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib77","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2460\/javma.1985.187.06.617","article-title":"Splenectomy as adjunctive therapy for immune-mediated thrombocytopenia and hemolytic anemia in the dog","volume":"187","author":"Feldman","year":"1985","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib78","first-page":"254","article-title":"Splenectomy as an adjunctive treatment for dogs with immune-mediated hemolytic anemia: ten cases (2003-2006)","volume":"19","author":"Horgan","year":"2009","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib79","first-page":"88","article-title":"Consensus on the rational use of antithrombotics in veterinary critical care (CURATIVE): domain 5-discontinuation of anticoagulant therapy in small animals","volume":"29","author":"Brainard","year":"2019","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jvim.12265","article-title":"Oral cyclosporine treatment in dogs: a review of the literature","volume":"28","author":"Archer","year":"2014","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib81","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jvp.12280","article-title":"Effects of oral cyclosporine on canine T-cell expression of IL-2 and IFN-gamma across a 12-h dosing interval","volume":"39","author":"Fellman","year":"2016","journal-title":"J\u00a0Vet Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib82","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00007890-199601150-00018","article-title":"Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measurement of inosine monophosphate dehydrogenase activity in a canine model","volume":"61","author":"Langman","year":"1996","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cvsm.2020.07.010_bib83","doi-asserted-by":"crossref","first-page":"e0154429","DOI":"10.1371\/journal.pone.0154429","article-title":"In\u00a0vitro influence of mycophenolic acid on selected parameters of stimulated peripheral canine lymphocytes","volume":"11","author":"Guzera","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib84","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/jvp.12420","article-title":"Pharmacokinetics and dynamics of mycophenolate mofetil after single-dose oral administration in juvenile dachshunds","volume":"40","author":"Grobman","year":"2017","journal-title":"J\u00a0Vet Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib85","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.tcam.2012.07.002","article-title":"Diseases associated with thrombosis","volume":"27","author":"de Laforcade","year":"2012","journal-title":"Top Companion Anim Med"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib86","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1939-1676.2010.0593.x","article-title":"Concurrent diseases and conditions in dogs with splenic vein thrombosis","volume":"24","author":"Laurenson","year":"2010","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib87","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1939-1676.2012.00893.x","article-title":"Portal vein thrombosis in 33 dogs: 1998-2011","volume":"26","author":"Respess","year":"2012","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/030098589303000104","article-title":"Thrombosis of the portal-vein in 11 dogs","volume":"30","author":"Vanwinkle","year":"1993","journal-title":"Vet Pathol"},{"issue":"12","key":"10.1016\/j.cvsm.2020.07.010_bib89","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.2460\/javma.1989.195.12.1748","article-title":"Idiopathic pleural effusion and pulmonary thromboembolism in a dog with autoimmune hemolytic anemia","volume":"195","author":"Bunch","year":"1989","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib90","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1939-1676.1999.tb02192.x","article-title":"Pulmonary thromboembolism in 29 dogs: 1985-1995","volume":"13","author":"Johnson","year":"1999","journal-title":"J\u00a0Vet Intern Med"},{"issue":"8","key":"10.1016\/j.cvsm.2020.07.010_bib91","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2460\/javma.2001.218.1308","article-title":"Correlation between leukocytosis and necropsy findings in dogs with immune-mediated hemolytic anemia: 34 cases (1994-1999)","volume":"218","author":"McManus","year":"2001","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib92","first-page":"681","article-title":"Thromboelastography in dogs with immune-mediated hemolytic anemia treated with prednisone, azathioprine and low-dose aspirin","volume":"24","author":"Flint","year":"2010","journal-title":"J\u00a0Vet Intern Med"},{"issue":"10","key":"10.1016\/j.cvsm.2020.07.010_bib93","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2460\/ajvr.72.10.1325","article-title":"Independent and combined effects of prednisone and acetylsalicylic acid on thromboelastography variables in healthy dogs","volume":"72","author":"Flint","year":"2011","journal-title":"Am J Vet Res"},{"issue":"5","key":"10.1016\/j.cvsm.2020.07.010_bib94","first-page":"471","article-title":"A\u00a0review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin","volume":"21","author":"Spurlock","year":"2011","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib95","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1939-1676.2009.0402.x","article-title":"Prothrombotic and inflammatory effects of intravenous administration of human immunoglobulin G in dogs","volume":"23","author":"Tsuchiya","year":"2009","journal-title":"J\u00a0Vet Intern Med"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib96","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2460\/javma.1999.215.06.798","article-title":"Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit","volume":"215","author":"Bateman","year":"1999","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib97","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1939-1676.2008.0058.x","article-title":"Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation","volume":"22","author":"Wiinberg","year":"2008","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib98","first-page":"3","article-title":"Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia","volume":"23","author":"Kidd","year":"2013","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib99","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1939-1676.2010.0642.x","article-title":"Use of serum concentrations of interleukin-18 and monocyte chemoattractant protein-1 as prognostic indicators in primary immune-mediated hemolytic anemia in dogs","volume":"25","author":"Kjelgaard-Hansen","year":"2011","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3\u20134","key":"10.1016\/j.cvsm.2020.07.010_bib100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.vetimm.2011.08.010","article-title":"High intravascular tissue factor expression in dogs with idiopathic immune-mediated haemolytic anaemia","volume":"144","author":"Piek","year":"2011","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib101","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/jvim.12583","article-title":"Procoagulant microparticles in dogs with immune-mediated hemolytic anemia","volume":"29","author":"Kidd","year":"2015","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib102","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2460\/javma.238.4.463","article-title":"Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia by means of thromboelastography","volume":"238","author":"Fenty","year":"2011","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib103","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tvjl.2011.03.015","article-title":"Serial assessment of the coagulation status of dogs with immune-mediated haemolytic anaemia using thromboelastography","volume":"191","author":"Goggs","year":"2012","journal-title":"Vet J"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib104","first-page":"682","article-title":"Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia","volume":"20","author":"Weiss","year":"2006","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0300985817699860","article-title":"Canine neutrophil extracellular traps enhance clot formation and delay lysis","volume":"55","author":"Jeffery","year":"2018","journal-title":"Vet Pathol"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib106","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jvim.14881","article-title":"Neutrophil extracellular traps in plasma from dogs with immune-mediated hemolytic anemia","volume":"32","author":"Lawson","year":"2018","journal-title":"J\u00a0Vet Intern Med"},{"issue":"5","key":"10.1016\/j.cvsm.2020.07.010_bib107","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/jvim.14808","article-title":"Cell-Free DNA and DNase activity in dogs with immune-mediated hemolytic anemia","volume":"31","author":"Jeffery","year":"2017","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3\u20134","key":"10.1016\/j.cvsm.2020.07.010_bib108","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.vetimm.2015.10.014","article-title":"Dogs cast NETs too: Canine neutrophil extracellular traps in health and immune-mediated hemolytic anemia","volume":"168","author":"Jeffery","year":"2015","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib109","first-page":"49","article-title":"Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 2-Defining rational therapeutic usage","volume":"29","author":"Goggs","year":"2019","journal-title":"J\u00a0Vet Emerg Crit Care"},{"key":"10.1016\/j.cvsm.2020.07.010_bib110","first-page":"5283","article-title":"Vascular bed-specific thrombosis","author":"Aird","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7","key":"10.1016\/j.cvsm.2020.07.010_bib111","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI60229","article-title":"New insights into the mechanisms of venous thrombosis","volume":"122","author":"Mackman","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.cvsm.2020.07.010_bib112","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/CCM.0000000000001670","article-title":"The fragility index in multicenter randomized controlled critical care trials","volume":"44","author":"Ridgeon","year":"2016","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.cvsm.2020.07.010_bib113","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2460\/ajvr.1980.41.11.1793","article-title":"Activated coagulation time in monitoring heparinized dogs","volume":"41","author":"Green","year":"1980","journal-title":"Am J Vet Res"},{"issue":"7","key":"10.1016\/j.cvsm.2020.07.010_bib114","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.2460\/ajvr.1985.46.07.1460","article-title":"Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog","volume":"46","author":"Hellebrekers","year":"1985","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/104063870301500615","article-title":"Heparin in\u00a0vitro sensitivity of the activated partial thromboplastin time in canine plasma depends on reagent","volume":"15","author":"Mischke","year":"2003","journal-title":"J\u00a0Vet Diagn Invest"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib116","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1939-1676.2012.00907.x","article-title":"Sonoclot(R) evaluation of single- and multiple-dose subcutaneous unfractionated heparin therapy in healthy adult dogs","volume":"26","author":"Babski","year":"2012","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib117","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1939-165X.2008.00068.x","article-title":"In\u00a0vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time","volume":"37","author":"Jessen","year":"2008","journal-title":"Vet Clin Pathol"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib118","first-page":"421","article-title":"Clinical experience of anti-Xa monitoring in critically ill dogs receiving dalteparin","volume":"24","author":"Lynch","year":"2014","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib119","first-page":"71","article-title":"Thromboelastographic monitoring of the effect of unfractionated heparin in healthy dogs","volume":"27","author":"McLaughlin","year":"2017","journal-title":"J\u00a0Vet Emerg Crit Care"},{"key":"10.1016\/j.cvsm.2020.07.010_bib120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tvjl.2016.01.018","article-title":"Enoxaparin has no significant anticoagulation activity in healthy Beagles at a dose of 0.8\u00a0mg\/kg four times daily","volume":"210","author":"Pouzot-Nevoret","year":"2016","journal-title":"Vet J"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib121","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1939-165X.2011.00282.x","article-title":"Monitoring unfractionated heparin therapy in dogs by measuring thrombin generation","volume":"40","author":"Allegret","year":"2011","journal-title":"Vet Clin Pathol"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib122","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/vcp.12489","article-title":"Effect of dalteparin administration on thrombin generation kinetics in healthy dogs","volume":"46","author":"Gara-Boivin","year":"2017","journal-title":"Vet Clin Pathol"},{"issue":"S1","key":"10.1016\/j.cvsm.2020.07.010_bib123","first-page":"S4","article-title":"Thromboelastography or activated partial thromboplastin time for heparin anticoagulation to prevent thrombosis: the TOPHATT trial","volume":"27","author":"Hanel","year":"2017","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib124","first-page":"75","article-title":"Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 4-Refining and monitoring antithrombotic therapies","volume":"29","author":"Sharp","year":"2019","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5326\/0450261","article-title":"Pharmacokinetics of subcutaneous low molecular weight heparin (enoxaparin) in dogs","volume":"45","author":"Lunsford","year":"2009","journal-title":"J\u00a0Am Anim Hosp Assoc"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib126","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0049-3848(85)90137-9","article-title":"Comparative effects of heparin and PK 10169, a low molecular weight fraction, in a canine model of arterial thrombosis","volume":"38","author":"Mestre","year":"1985","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib127","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0049-3848(00)00334-0","article-title":"Anti-thrombotic efficacies of enoxaparin, dalteparin, and unfractionated heparin in venous thrombo-embolism","volume":"100","author":"Morris","year":"2000","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib128","first-page":"60","article-title":"Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 3-Defining antithrombotic protocols","volume":"29","author":"Blais","year":"2019","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"7","key":"10.1016\/j.cvsm.2020.07.010_bib129","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2460\/ajvr.71.7.822","article-title":"Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs","volume":"71","author":"Brainard","year":"2010","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib130","first-page":"256","article-title":"Mitral valve repair in dogs using an ePTFE chordal implantation device: a pilot study","volume":"19","author":"Borgarelli","year":"2017","journal-title":"J\u00a0Vet Cardiol"},{"issue":"5","key":"10.1016\/j.cvsm.2020.07.010_bib131","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1055\/s-0037-1616065","article-title":"Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries","volume":"86","author":"Hasa","year":"2001","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.cvsm.2020.07.010_bib132","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.thromres.2009.06.029","article-title":"Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis\/hemostasis","volume":"124","author":"van Giezen","year":"2009","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib133","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.thromres.2013.01.029","article-title":"High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition","volume":"131","author":"Bjorkman","year":"2013","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib134","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/jvim.12022","article-title":"Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin","volume":"27","author":"Dudley","year":"2013","journal-title":"J\u00a0Vet Intern Med"},{"issue":"11","key":"10.1016\/j.cvsm.2020.07.010_bib135","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2460\/ajvr.71.11.1294","article-title":"Influence of treatment with ultralow-dose aspirin on platelet aggregation as measured by whole blood impedance aggregometry and platelet P-selectin expression in clinically normal dogs","volume":"71","author":"Sharpe","year":"2010","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2020.07.010_bib136","first-page":"1282","article-title":"Platelet function and endoscopic changes after clopidogrel, aspirin, prednisone, or combination therapy in dogs","volume":"31","author":"Whittemore","year":"2017","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib137","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00217308","article-title":"Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. An enzyme-histochemical study","volume":"238","author":"van Rooijen","year":"1984","journal-title":"Cell Tissue Res"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib138","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1182\/blood-2001-11-0061","article-title":"Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model","volume":"101","author":"Jordan","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cvsm.2020.07.010_bib139","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.exphem.2006.05.014","article-title":"Evaluation of liposomal clodronate in experimental spontaneous autoimmune hemolytic anemia in dogs","volume":"34","author":"Mathes","year":"2006","journal-title":"Exp Hematol"},{"issue":"5","key":"10.1016\/j.cvsm.2020.07.010_bib140","first-page":"423","article-title":"The modulatory role of melatonin on immune responsiveness","volume":"7","author":"Carrillo-Vico","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib141","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00045391-200211000-00012","article-title":"Melatonin for refractory idiopathic thrombocytopenic purpura: a report of 3 cases","volume":"9","author":"Todisco","year":"2002","journal-title":"Am J Ther"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib142","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12916-017-1000-8","article-title":"Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action","volume":"16","author":"Posadzki","year":"2018","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib143","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/jvp.12749","article-title":"Pharmacodynamic evaluation of the effects of oral melatonin on expression of the T-cell cytokines interleukin-2 and interferon gamma in the dog","volume":"42","author":"Peace","year":"2019","journal-title":"J\u00a0Vet Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib144","first-page":"284","article-title":"Hyperbaric oxygen therapy. Part 1: history and principles","volume":"20","author":"Edwards","year":"2010","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib145","first-page":"289","article-title":"Hyperbaric oxygen therapy. Part 2: application in disease","volume":"20","author":"Edwards","year":"2010","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib146","first-page":"61","article-title":"A\u00a0systematic review of the application of hyperbaric oxygen in the treatment of severe anemia: an evidence-based approach","volume":"32","author":"Van Meter","year":"2005","journal-title":"Undersea Hyperb Med"},{"issue":"10","key":"10.1016\/j.cvsm.2020.07.010_bib147","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jama.1974.03230230037020","article-title":"Hyperbaric oxygen in hemolytic crisis","volume":"227","author":"Myking","year":"1974","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib148","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/jvim.15528","article-title":"Membrane-based therapeutic plasma exchange in dogs: Prescription, anticoagulation, and metabolic response","volume":"33","author":"Francey","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib149","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J\u00a0Clin Apher"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib150","first-page":"375","article-title":"Use of therapeutic plasmapheresis in a case of canine immune-mediated hemolytic anemia","volume":"19","author":"Crump","year":"2009","journal-title":"J\u00a0Vet Emerg Crit Care"},{"issue":"9","key":"10.1016\/j.cvsm.2020.07.010_bib151","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2460\/javma.252.9.1108","article-title":"Effects of therapeutic plasma exchange on serum immunoglobulin concentrations in a dog with refractory immune-mediated hemolytic anemia","volume":"252","author":"Scagnelli","year":"2018","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"5","key":"10.1016\/j.cvsm.2020.07.010_bib152","first-page":"549","article-title":"Successful management of acute bilirubin encephalopathy in a dog with immune-mediated hemolytic anemia using therapeutic plasma exchange","volume":"29","author":"Heffner","year":"2019","journal-title":"J\u00a0Vet Emerg Crit Care"},{"key":"10.1016\/j.cvsm.2020.07.010_bib153","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tvjl.2015.10.022","article-title":"Novel immunotherapies for immune-mediated haemolytic anaemia in dogs and people","volume":"207","author":"Swann","year":"2016","journal-title":"Vet J"},{"key":"10.1016\/j.cvsm.2020.07.010_bib154","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tvjl.2015.10.008","article-title":"Cancer immunotherapy in veterinary medicine: Current options and new developments","volume":"207","author":"Regan","year":"2016","journal-title":"Vet J"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib155","first-page":"189","article-title":"B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia","volume":"87","author":"Zaja","year":"2002","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib156","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.autrev.2014.11.014","article-title":"Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies","volume":"14","author":"Reynaud","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.cvsm.2020.07.010_bib157","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in\u00a0vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cvsm.2020.07.010_bib158","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1354\/vp.42-4-468","article-title":"CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma","volume":"42","author":"Jubala","year":"2005","journal-title":"Vet Pathol"},{"issue":"3\u20134","key":"10.1016\/j.cvsm.2020.07.010_bib161","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.vetimm.2015.02.004","article-title":"Identification of a candidate therapeutic antibody for treatment of canine B-cell lymphoma","volume":"164","author":"Rue","year":"2015","journal-title":"Vet Immunol Immunopathol"},{"issue":"22","key":"10.1016\/j.cvsm.2020.07.010_bib162","first-page":"2459","article-title":"Complement in hemolytic anemia","volume":"126","author":"Brodsky","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"18","key":"10.1016\/j.cvsm.2020.07.010_bib163","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"124","author":"Brodsky","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cvsm.2020.07.010_bib164","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","article-title":"Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria","volume":"110","author":"Hillmen","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib165","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jvim.14871","article-title":"In\u00a0vitro Inhibition of Canine Complement-Mediated Hemolysis","volume":"32","author":"Hernandez","year":"2018","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2020.07.010_bib166","doi-asserted-by":"crossref","first-page":"20366","DOI":"10.1016\/j.vetimm.2018.08.006","article-title":"Pharmacokinetics of human recombinant C1-esterase inhibitor and development of anti-drug antibodies in healthy dogs","volume":"203","author":"Wong","year":"2018","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.cvsm.2020.07.010_bib167","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/ajrccm.155.3.9117001","article-title":"C1-esterase inhibitor prevents early pulmonary dysfunction after lung transplantation in the dog","volume":"155","author":"Salvatierra","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.cvsm.2020.07.010_bib168","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1172\/JCI116516","article-title":"Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor","volume":"91","author":"Guerrero","year":"1993","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.cvsm.2020.07.010_bib169","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1182\/blood-2012-11-467209","article-title":"C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia","volume":"121","author":"Wouters","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cvsm.2020.07.010_bib170","doi-asserted-by":"crossref","first-page":"363278","DOI":"10.1155\/2015\/363278","article-title":"Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy","volume":"2015","author":"Berentsen","year":"2015","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.cvsm.2020.07.010_bib171","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12917-019-2220-2","article-title":"C1 inhibitor in canine intravascular hemolysis (C1INCH): study protocol for a randomized controlled trial","volume":"15","author":"Goggs","year":"2019","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.cvsm.2020.07.010_bib172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tvjl.2015.11.018","article-title":"A\u00a0brighter future for dogs with immune-mediated haemolytic anaemia","volume":"209","author":"Mizuno","year":"2016","journal-title":"Vet J"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561620300772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561620300772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:47:03Z","timestamp":1759283223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561620300772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":170,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0195561620300772"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2020.07.010","relation":{},"ISSN":["0195-5616"],"issn-type":[{"value":"0195-5616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Small Animal Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cvsm.2020.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}